» Articles » PMID: 26303068

Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD

Overview
Specialty Nephrology
Date 2015 Aug 26
PMID 26303068
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Traditional histologic methods are limited in their ability to detect pathologic changes of CKD, of which cisplatin therapy is an important cause. In addition, poor reproducibility of available methods has limited analysis of the role of fibrosis in CKD. Highly labor-intensive serial sectioning studies have demonstrated that three-dimensional perspective can reveal useful morphologic information on cisplatin-induced CKD. By applying the new technique of multiphoton microscopy (MPM) with clearing to a new mouse model of cisplatin-induced CKD, we obtained detailed morphologic and collagen reconstructions of millimeter-thick renal sections that provided new insights into pathophysiology. Quantitative analysis revealed that a major long-term cisplatin effect is reduction in the number of cuboidal cells of the glomerular capsule, a change we term the "uncapped glomerulus lesion." Glomerulotubular disconnection was confirmed, but connection remnants between damaged tubules and atubular glomeruli were observed. Reductions in normal glomerular capsules corresponded to reductions in GFR. Mild increases in collagen were noted, but the fibrosis was not spatially correlated with atubular glomeruli. Glomerular volume and number remained unaltered with cisplatin exposure, but cortical tubulointerstitial mass decreased. In conclusion, new observations were made possible by using clearing MPM, demonstrating the utility of this technique for studies of renal disease. This technique should prove valuable for further characterizing the evolution of CKD with cisplatin therapy and of other conditions.

Citing Articles

Ultrasound-guided renal subcapsular transplantation of mesenchymal stem cells for treatment of acute kidney injury in a minipig model: safety and efficacy evaluation.

Xiao T, Chen Y, Jiang B, Huang M, Liang Y, Xu Y Stem Cell Res Ther. 2025; 16(1):102.

PMID: 40022148 PMC: 11871648. DOI: 10.1186/s13287-025-04137-4.


Understanding Cisplatin Pharmacokinetics and Toxicodynamics to Predict and Prevent Kidney Injury.

Thompson L, Joy M J Pharmacol Exp Ther. 2024; 391(3):399-414.

PMID: 39322416 PMC: 11585315. DOI: 10.1124/jpet.124.002287.


Adenine-induced animal model of chronic kidney disease: current applications and future perspectives.

Yang Q, Su S, Luo N, Cao G Ren Fail. 2024; 46(1):2336128.

PMID: 38575340 PMC: 10997364. DOI: 10.1080/0886022X.2024.2336128.


Data retrieval from archival renal biopsies using nonlinear microscopy.

Cahill L, Yoshitake T, Rosen M, Weber T, Fujimoto J, Rosen S PLoS One. 2024; 19(3):e0299506.

PMID: 38489324 PMC: 10942027. DOI: 10.1371/journal.pone.0299506.


Rodent models of AKI and AKI-CKD transition: an update in 2024.

Fu Y, Xiang Y, Wei Q, Ilatovskaya D, Dong Z Am J Physiol Renal Physiol. 2024; 326(4):F563-F583.

PMID: 38299215 PMC: 11208034. DOI: 10.1152/ajprenal.00402.2023.


References
1.
Mason S, Hader C, Marlier A, Moeckel G, Cantley L . Met activation is required for early cytoprotection after ischemic kidney injury. J Am Soc Nephrol. 2013; 25(2):329-37. PMC: 3904569. DOI: 10.1681/ASN.2013050473. View

2.
Soda K, Balkin D, Ferguson S, Paradise S, Milosevic I, Giovedi S . Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. J Clin Invest. 2012; 122(12):4401-11. PMC: 3533561. DOI: 10.1172/JCI65289. View

3.
Huen S, Moeckel G, Cantley L . Macrophage-specific deletion of transforming growth factor-β1 does not prevent renal fibrosis after severe ischemia-reperfusion or obstructive injury. Am J Physiol Renal Physiol. 2013; 305(4):F477-84. PMC: 3891258. DOI: 10.1152/ajprenal.00624.2012. View

4.
Kollmannsberger C, Kuzcyk M, Mayer F, Hartmann J, Kanz L, Bokemeyer C . Late toxicity following curative treatment of testicular cancer. Semin Surg Oncol. 1999; 17(4):275-81. DOI: 10.1002/(sici)1098-2388(199912)17:4<275::aid-ssu9>3.0.co;2-u. View

5.
Fossa S, Aass N, Winderen M, Bormer O, Olsen D . Long-term renal function after treatment for malignant germ-cell tumours. Ann Oncol. 2002; 13(2):222-8. DOI: 10.1093/annonc/mdf048. View